Open AccessDiabetic foot gangrene patient with multi-drug resistant Pseudomonas putida infection in Karawaci District, Indonesia
Author(s) -
Nata Pratama Hardjo Lugito,
Cucu Nawangsih,
Jevany Claudia Moksidy,
Andree Kurniawan,
Margaret Merlyn Tjiang
Publication year - 2015
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.146378
Subject(s) - pseudomonas putida , amikacin , osteomyelitis , gangrene , amputation , medicine , metronidazole , ceftriaxone , antibiotics , surgery , cellulitis , foot (prosody) , diabetic foot , pseudomonas aeruginosa , microbiology and biotechnology , diabetes mellitus , biology , bacteria , endocrinology , linguistics , philosophy , genetics
Pseudomonas putida is a rod-shaped, non fermenting Gram-negative organism frequently found in the environment that utilizes aerobic metabolism, previously thought to be of low pathogenicity. It had been reported as cause of skin and soft tissue infection, especially in immunocompromised patients. A female green grocer, 51 year-old came to internal medicine out-patient clinic with gangrene and osteomyelitis on her 1(st), 2(nd) and 3(rd) digit and wound on the sole of the right foot since 1 month prior. The patient had history of uncontrolled diabetes since a year ago. She was given ceftriaxone 2 grams b.i.d, metronidazole 500 mg t.i.d empirically and then amikacin 250 mg b.i.d, followed by amputation of the digits and wound debridement. The microorganism's culture from pus revealed multi drug resistant Pseudomonas putida. She recovered well after antibiotics and surgery.